| Literature DB >> 31644322 |
Jing Hu1, Bo Han1, Jiaoti Huang1.
Abstract
CONTEXT.—: The incidence of neuroendocrine tumors of the prostate increases after hormonal therapy. Neuroendocrine tumors possess a broad spectrum of morphologic features and pose challenges in the pathologic diagnosis and clinical management of patients. OBJECTIVE.—: To present a brief updated summary of neuroendocrine tumors of the prostate with an overview of their histopathologic and immunohistochemical profiles and differential diagnoses. DATA SOURCES.—: Literature review, personal experience in the daily practice of pathologic diagnosis, and laboratory research. CONCLUSIONS.—: Our understanding of neuroendocrine tumors of the prostate classification and diagnosis continues to evolve. These advances benefit the risk stratification and management of prostate cancer.Entities:
Year: 2019 PMID: 31644322 DOI: 10.5858/arpa.2019-0434-RA
Source DB: PubMed Journal: Arch Pathol Lab Med ISSN: 0003-9985 Impact factor: 5.534